Morinda citrifolia, has been reported to posses different biological activities and almost all parts of this have been studied phytochemically. However there are few studies on the seeds of fruit. The objective of present study was investigated the effect to Noni Seed Oil (NSO) on serum lipid levels in normolipidemic and hyperlipidemic induced mice. We find that administration of noni oil causes a reduction in total cholesterol and triglycerides levels in both models. However hypolipidemic effect is higher when hyperlipidemia is presented.
Morinda citrifolia L. (Rubiaceae) commonly known as noni, is an evergreen tree may reach heights of 3 to 8 m tall. Its leaves range from 10 to 45 cm long and it bears tubular white flowers and a green fruit. This fruit turns yellow and then white as it ripens, has a pungent odor and contains seeds of about 3 mm in length. This plant is native to Asia, Australia and Polynesia [1] . The plant is used in the treatment of arthritis, headaches, digestive problems, diabetes mellitus, high blood pressure, and angina pectoris among others [2] . The Leaves, steam, root, fruit and seeds of noni are used in various forms such as capsules, teas, juice and oil [2, 3] .
Due to the great popularity of this plant many phytochemical studies have been carried out in which have reported compounds as iridoids, anthraquinones phenolics, glycosides of fatty acids and alcohols, cumarins, flavonoids, alkaloids and terpenes [4] . Regarding the biological activity of this specie, the antimicrobial effect was the first observed property [5] , however other effects like antitubercular [6] , hypoglycemic [7], antiinflammatory [8], antitumor [9] and analgesic [10] have been reported.
Among these one evaluated the toxicity and nutritional value, as well as the determination of the fatty acid composition to assess if it is usable as edible vegetable oil. Seeds constitute 2.5% of the whole fruit and are considered a waste in the industrial process for making juice [3] . Although anthraquinones and fatty acids such as arachidonic and palmitoleic have been isolated from these seeds, it has not been established whether they show any biological activity [1] .
Hyperlipidemic is defined as elevated lipid levels in plasma, and represent one of the factors associated with cardiovascular diseases, which are a worldwide death cause [11] [12] [13] . Treatment of dyslipidemia reduces cardiovascular events. The modern pharmacological therapy for abnormal lipids is effective but is expensive and it is associated with side-effects leading to patient incompliance. For this reason, our work evaluates the effect of NSO on lipid levels (total cholesterol (chol), triglyceride (Tg), high density lipoprotein (chol-HDL), in normolipidemic and hyperlipidemic mice. Castelli's Atherogenic Index (AI) was calculated for determined risk factor of cardiovascular disease with noni seed oil consumed. 
Analysis of NSO
The total yield of oil for two extractions of dried seeds was 12%. GC-MS analysis of the FAME (fatty acid methyl esters) prepared by transesterification procedure indicated the presence of five fatty acids with the relative composition shown in Table 1 . The FAME showed mass spectra with molecular ions at m/z 270, 268, 298, 296 and 294, corresponding to the retention times of 38.5, 39.2, 42.5, 43.1, 44.2 min. These times indicated the presence of palmitic (C16), palmitoleic (C16:1), stearic (C18:0), oleic (C18:1) and linoleic (C18:2) fatty acids respectively, being the principal component linoleic acid. However further studies are necessary to determine the exact chemical composition.
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Biological assay: Data on the effect on lipid-lowering activity of the three parameters evaluated are summarized in Tables 2 and 3 . All animals showed good health during the period of administration. At necropsy no changes were found in the organs of the treated animals.
Animals administered with 600 mg/Kg (Table 2) registered the most important effect with a reduction of -19.09% and -33.7% for total cholesterol and triglycerides respectively. These results suggest a hypolipidemic activity of seed oil and a relationship between dose and effect.
Treatment of ICR mice with Triton WR 1339 (tyloxapol) resulted in a significant elevation in total serum cholesterol, HDL-cholesterol and triglycerides respect to control.
Tyloxapol is a non-ionic surfactant being widely used to explore possible mechanism of lipid lowering drugs, it causes drastic increase in serum triglycerides and cholesterol levels due to increase in hepatic cholesterol synthesis particularly by the increase in HMG Co-A (3-hydroxy-3-methyl-glutaryl Co-A) activity and by the inhibition of lipoprotein lipase responsible for hydrolysis of plasma lipids [14] .
The Table 3 shows data about the use of NSO in hyperlipidemic mice. The lowest reduction values for cholesterol (-22.15%) and triglycerides (-74.2%) were obtained with dose of 150 mg/kg, exhibiting the best hypolipidemic effect. Not relationship dose-effect in cholesterol was observed. Nevertheless for triglycerides is notorious inverse relationship dose-effect.
Significant inhibition of lipid levels increase by noni seed oil of Morinda citrifolia in this model is indicative of the Various indices have been used for the diagnosis and prognosis of cardiovascular disease, one of them was reported by Castelli [11] . Castelli's Atherogenic index (AI) is total cholesterol/HDL ratio and it is considered that a value below than four units represents a low risk of cardiovascular disease [11] [12] [13] . AIs were calculated for the different groups, being that it is smaller for normolipidemic group when administered NSO (Figure 1) . While for the hyperlipidemic group a slight decrease regarding the control is observed only at dose of 300 mg/Kg. However the values for this group stay below the one it limits.
We find that the administration of noni oil causes a hypolipidemic effect, mainly evident when hyperlipidemia occurs. The results from this study rationalize the medicinal use of noni seed oil in dislipidemia. However further studies are required to prove efficacy of noni seed oil in dyslipidemia and to prove that it can be used as a potential medicine for cardiovascular diseases.
The main constituent of noni seed oil is linoleic acid, however hypolipidemic activity may be due to the presence of other compounds in oil.
Experimental

Extraction seed oil (NSO):
The noni fruit was obtained from Córdoba Veracruz, México. The seeds were obtained from fresh fruits. The batch of seeds were washed and dried at room temperature. Dried seeds were ground and extracted by maceration with food-grade hexane at 1:5 ratio at room temperature for 24 h. The extract was filtered and the solvent removed by distillation under reduced pressure. The crude oil was used in the bioassay.
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Oil analysis: Fatty acid composition was determined for gas chromatography (GC) of methyl ester obtained after transesterification of the crude oil [15] on a Hewlett-Packard 5890 Series II Gas Chromatograph equipped with a 5971A Mass Selective detector and using an HP-Innowax capillary column (30 m x 0.2 mm x 0.25 μm thick coating). Helium was used as the carrier gas at a flow rate of 1 mL/min with the injector set to split mode at 250ºC. The oven was programmed from 100 to 140°C at 1.5°C/min and then from 140 to 250°C at 5°C/min and held at 250ºC for 10 min. The detector was operated at 70 eV in scanning mode over the range of 50-550 amu. Mass spectra were compared with data in NIS library and % of fatty acid was calculated for integration value for chromatogram.
Hypolipidemic Evaluation: Hypolipidemic activity was studied in (ICR) male mice weighing 25-30g (Birmex, S. A., Mexico City). All animals were housed in hanging metal cages and maintained at 24±2 ºC and 50±10% relative humidity, with 12 h light/dark cycle. They were fed on standard pellet diets (Rodent Diet 5001, PMI Nutrition International, Inc. Brenwood, MO) and drinking water was freely available. All animals appeared healthy throughout the dosing period, maintaining normal food intake and weight gain. At sacrifice, no gross abnormalities were observed in any treated mice.
All animals were treated in accordance with ethical principles and regulations specified by the Animal Care and Use Committee of our institution and the standards of the National Institutes of Health of Mexico.
The mice were randomly divided into groups of six animals. Hyperlipidemia was induced in the mice by administration of Triton WR 1339 (Tyloxapol) was dissolved in water at 400 mg/Kg. The seed oil was administered 1h before and 22 and 48 h after the tyloxapol injection [16] .
Mice were treated with the oil seed suspended in a 1:4.5:4.5 tween 80: mineral oil: saline solution and administered orally by an incubation needle at doses of 150, 300 or 600 mg/Kg/day for 28 days. Animals receiving the vehicle were used as the non-cholesterol control group.
For tyloxapol-treated mice blood samples were taken 48 h after injection. On the other hand, animals receiving treatment for 28 days were fasted for 12 h before sacrifice. Blood samples were collected by periorbital plexus bleeding and centrifuged at 3000 rpm for 15 min. Total cholesterol (Col), high-density lipoprotein cholesterol (col-HDL), and triglycerides (Tg) levels were determined in the serum, using a Wiener lab, Selectra 2000 automatic analyzer.
All data are expressed as the percentage of the cholesterol group control (the mean± standard error) by using Student 9t test. P values less than 0.05 considered statistically significant.
Castelli Atherogenic index (AI) were calculated using the equation IA= Total cholesterol/HDL-chol [11] .
